In prostate cancer, a DNA microarray demonstrated that MTA1 is selectively over-expressed in metastatic prostate cancer compared to clinically localized prostate cancer or benign prostate tissue [4], [36]. This evidence concerns the gene MTA1 and metastatic prostate carcinoma.